SHBG, sex hormone binding globulin, 6462

N. diseases: 368; N. variants: 20
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 Biomarker disease BEFREE Women with NC-CAH had significantly lower orgasm scores, a trend toward lower sexual function with higher sexual distress, as well as biochemical evidence of hyperandrogenism (higher dehydroepiandrosterone sulfate and lower SHBG) and a trend toward more clinical signs of hyperandrogenism (hirsutism). 31447379 2019
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 Biomarker disease BEFREE <b>Abbreviations</b>: AUC: area under curve; BMI: body mass index; C: cholesterol; CI: confidence interval; DBP: diastolic blood pressure; DHEAS: dehydroepiandrosterone sulfate; FG: Ferriman-Gallway; FSH: follicle stimulating hormone; GHQ: general health questionnaire; HA: hyperandrogenism; HDL-C: high-density lipoprotein cholesterol; HOMA-IR: homeostatic model assessment for insulin resistance; HWR: hip waist ratio; LDL-C: low-density lipoprotein cholesterol; LH: luteinizing hormone; LH: luteinizing hormone; LHR: lutropin receptor; O: oligomenorrhea; OR: odds ratio; PCO: polycystic ovaries; PCO: polycystic ovary; PCOS: polycystic ovary syndrome; PCR: polymerase chain reaction; ROC: receiver operating curve; SBP: systolic blood pressure; SE: standard error of coefficient; SNP: single nucleotide polymorphism; TG: triglycerides; TSH: thyroid stimulating hormone; VD: vitamin D. 30958034 2019
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 Biomarker disease BEFREE A reduction in plasma sex hormone-binding globulin (SHBG), a transport carrier that binds estrogen and androgens and regulates their biological activities, is often used as an indicator of hyperandrogenism in women with PCOS. 31525346 2019
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 Biomarker disease BEFREE Nonobese patients with PCOS have adrenal hyperandrogenism as the underlying mechanism while their obese/ insulin-resistant counterparts have low SHBG and hence an increased fraction of free testosterone. 29068242 2018
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 AlteredExpression disease BEFREE According to reduced sex hormone-binding globulin levels and increased free androgen index in the present study, obesity was linked with hyperandrogenism in female subjects. 30232779 2018
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 Biomarker disease BEFREE The FAI is not a reliable indicator of free T when the SHBG concentration is low and would give misleading information in a large number of women being investigated for hyperandrogenism. 29405348 2018
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 Biomarker disease BEFREE These results were confirmed by a multiple regression analysis model in which adrenal hyperandrogenism was negatively associated with age (<i>P</i> < 0.001) and SHBG concentrations (<i>P</i> = 0.02), but not with any metabolic parameter. 28912337 2017
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 GeneticVariation disease BEFREE To our knowledge, these are the first examples of human SHBG variants linked to hyperandrogenism and ovarian dysfunction. 11927624 2002
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 Biomarker disease BEFREE Serum androgen, IGFBP-1, and SHBG concentrations; IRS-1 genotypes.Twenty-five of 54 (45%) girls with a history of PP developed hyperinsulinemic ovarian hyperandrogenism at adolescence. 12477526 2002
CUI: C0206081
Disease: Hyperandrogenism
Hyperandrogenism
0.100 Biomarker disease BEFREE This SHBG decrease is more pronounced in girls with premature pubarche who are at risk to develop functional ovarian hyperandrogenism as well as insulin resistance syndrome. 11117669 2000